|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquisition
|
gptkb:Taris_Biomedical
gptkb:Actelion
gptkb:Centocor
|
|
gptkbp:ceo
|
gptkb:Mathai_Mammen
|
|
gptkbp:clinical_trial
|
pediatric studies
Phase 3 trials
long-term studies
Phase 1 trials
Phase 2 trials
|
|
gptkbp:collaboration
|
gptkb:Mayo_Clinic
gptkb:Harvard_University
gptkb:Stanford_University
gptkb:University_of_Pennsylvania
gptkb:Cleveland_Clinic
|
|
gptkbp:established
|
gptkb:2013
|
|
gptkbp:focus_area
|
oncology
neuroscience
cardiovascular diseases
infectious diseases
immunology
|
|
gptkbp:founded_by
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:headquarters
|
gptkb:Horsham,_Pennsylvania
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Janssen Biotech
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:number_of_employees
|
over 1,000
|
|
gptkbp:parent_company
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:part_of
|
gptkb:Janssen_Pharmaceuticals
|
|
gptkbp:partnership
|
gptkb:Merck
gptkb:GSK
gptkb:Bristol-Myers_Squibb
gptkb:Amgen
gptkb:Abb_Vie
|
|
gptkbp:product
|
gptkb:Xarelto
gptkb:Stelara
gptkb:Remicade
gptkb:Tremfya
gptkb:Invega
Erleada
Darzalex
Spravato
Simponi
|
|
gptkbp:research_focus
|
biologics
small molecules
|
|
gptkbp:sustainability_initiatives
|
gptkb:healthcare_access
community engagement
diversity and inclusion
ethical sourcing
environmental responsibility
|
|
gptkbp:website
|
www.janssenbiotech.com
|
|
gptkbp:bfsParent
|
gptkb:siltuximab
|
|
gptkbp:bfsLayer
|
5
|